Prognostic Significance of Gallium Lung Scans in Sarcoidosis
1986; Wiley; Volume: 465; Issue: 1 Linguagem: Italiano
10.1111/j.1749-6632.1986.tb18520.x
ISSN1749-6632
AutoresAlbert H. Niden, Fred S. Mishkin, Frank A. Salem, Alvin V. Thomas, VIJAY KAMDAR,
Tópico(s)Infectious Diseases and Tuberculosis
ResumoAnnals of the New York Academy of SciencesVolume 465, Issue 1 p. 435-443 Prognostic Significance of Gallium Lung Scans in Sarcoidosis ALBERT H. NIDEN, ALBERT H. NIDEN Department of Medicine, Charles R. Drew Medical School University of California School of Medicine Los Angeles, CaliforniaSearch for more papers by this authorFRED S. MISHKIN, FRED S. MISHKIN Department of Radiology, Charles R. Drew Medical School University of California School of Medicine Los Angeles, CaliforniaSearch for more papers by this authorFRANK SALEM, FRANK SALEM Department of Pathology, Charles R. Drew Medical School University of California School of Medicine Los Angeles, CaliforniaSearch for more papers by this authorALVIN V. THOMAS JR., ALVIN V. THOMAS JR. Department of Medicine, Charles R. Drew Medical School University of California School of Medicine Los Angeles, CaliforniaSearch for more papers by this authorVIJAY KAMDAR, VIJAY KAMDAR Department of Medicine, Charles R. Drew Medical School University of California School of Medicine Los Angeles, CaliforniaSearch for more papers by this author ALBERT H. NIDEN, ALBERT H. NIDEN Department of Medicine, Charles R. Drew Medical School University of California School of Medicine Los Angeles, CaliforniaSearch for more papers by this authorFRED S. MISHKIN, FRED S. MISHKIN Department of Radiology, Charles R. Drew Medical School University of California School of Medicine Los Angeles, CaliforniaSearch for more papers by this authorFRANK SALEM, FRANK SALEM Department of Pathology, Charles R. Drew Medical School University of California School of Medicine Los Angeles, CaliforniaSearch for more papers by this authorALVIN V. THOMAS JR., ALVIN V. THOMAS JR. Department of Medicine, Charles R. Drew Medical School University of California School of Medicine Los Angeles, CaliforniaSearch for more papers by this authorVIJAY KAMDAR, VIJAY KAMDAR Department of Medicine, Charles R. Drew Medical School University of California School of Medicine Los Angeles, CaliforniaSearch for more papers by this author First published: June 1986 https://doi.org/10.1111/j.1749-6632.1986.tb18520.xCitations: 8AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 JAMES, D. G. & A. D. THOMPSON. 1959. The course of sarcoidosis and its modifications by treatment. Lancet i: 1057–1061. 10.1016/S0140-6736(59)90648-8 Google Scholar 2 SONES, M. & H. L. ISRAEL. 1960. The course and prognosis of sarcoidosis. Am. J. Med. 29: 84–93. 10.1016/0002-9343(60)90009-7 CASPubMedWeb of Science®Google Scholar 3 SCADDING, J. G. 1961. Prognosis of intrathoracic sarcoidosis in England: A review of 136 cases after 5 years' observation. Br. Med. J. 2: 1165–1172. 10.1136/bmj.2.5261.1165 CASPubMedWeb of Science®Google Scholar 4 ELLIS, K. & G. RENTHAL. 1962. Pulmonary sarcoidosis: Roentgenographic observations on the course of the disease. 1962. Am. J. Roentgenol. 88: 1070–1083. Web of Science®Google Scholar 5 RUGBERG-ROOS, I. 1962. The course and prognosis of sarcoidosis as observed in 296 cases. Acta Tuberc. Scand. 41: 1–42. Google Scholar 6 JAMES, D. G., L. S. CARSTAIRS, J. TROWELL & O. P. SHARMA. 1967. Treatment of sarcoidosis: Report of a controlled therapeutic trial. Lancet ii: 526–528. 10.1016/S0140-6736(67)90493-X Google Scholar 7 JOHNS, C. J., J. B. ZACHARY & W. C. BALL, JR. 1974. A ten-year study of corticosteroid treatment of pulmonary sarcoidosis. Johns Hopkins Med. J. 134: 271–283. CASPubMedWeb of Science®Google Scholar 8 JOHNS, C. J., M. I. MACGREGOR, J. B. ZACHARY & W. C. BALL. 1976. Extended experience in the long-term corticosteroid treatment of pulmonary sarcoidosis. Ann. N. Y. Acad. Sci. 278: 722–731. 10.1111/j.1749-6632.1976.tb47087.x CASPubMedWeb of Science®Google Scholar 9 STONE, O. J., A. SCHWARTZ, J. A. FELLMAN & F. J. LOVELOCK. 1953. Pulmonary function in sarcoidosis: Results with cortisone therapy. Am. J. Med. 15: 468–476. 10.1016/0002-9343(53)90137-5 CASPubMedWeb of Science®Google Scholar 10 SMELLIE, H., G. H. APTHORP & R. MARSHALL. 1961. The effect of corticosteroid treatment on pulmonary function in sarcoidosis. Thorax 16: 87–90. 10.1136/thx.16.1.87 Google Scholar 11 BOUSHY, S. F., R. S. KURTZMAN, N. D. MARTIN & G. M. LEWIS. 1965. The course of pulmonary function in sarcoidosis. Ann. Intern. Med. 62: 939–955. 10.7326/0003-4819-62-5-939 CASPubMedWeb of Science®Google Scholar 12 SHARMA, O. P., C. COLP & M. H. WILLIAMS. 1966. Course of pulmonary sarcoidosis with and without corticosteroid therapy as determined by pulmonary function studies. Am. J. Med. 41: 541–551. 10.1016/0002-9343(66)90216-6 CASPubMedWeb of Science®Google Scholar 13 STONE, R. J. & A. SCHWARTZ. 1966. Long-term study of sarcoid and its modification by steroid therapy: Lung function and other factors in prognosis. Am. J. Med. 41: 528–540. 10.1016/0002-9343(66)90215-4 CASPubMedWeb of Science®Google Scholar 14 EMIRGIL, C., B. J. SOBOL & M. H. WILLIAMS. 1969. Long-term study of pulmonary sarcoidosis: The effects of steroid therapy as evaluated by pulmonary function studies. J. Chronic Dis. 22: 69–86. 10.1016/0021-9681(69)90060-5 CASPubMedWeb of Science®Google Scholar 15 YOUNG, R. L., L. E. HARKLEROAD, R. E. LORDON & J. G. WEG. 1970. Pulmonary sarcoidosis: A prospective evaluation of glucocorticoid therapy. Ann. Intern. Med. 73: 207–212. 10.7326/0003-4819-73-2-207 PubMedWeb of Science®Google Scholar 16 BLOCK, A. J. & R. W. LIGHT. 1973. Alternate day steroid therapy in diffuse pulmonary sarcoidosis. Chest 63: 495–500. 10.1378/chest.63.4.495 CASPubMedWeb of Science®Google Scholar 17 ISRAEL, H. L., D. W. FOUTS & R. A. BEGGS. 1973. A controlled trial of prednisone treatment of sarcoidosis. Am. Rev. Respir. Dis. 107: 609–614. 10.1164/arrd.1973.107.4.609 CASPubMedWeb of Science®Google Scholar 18 REFVEM, O. 1974. Long-term corticosteroid treatment of pulmonary sarcoidosis. In Proceedings of the Sixth International Conference on Sarcoidosis. K. Iwai & Y. Hosoda, Eds.: 533–538. University Park Press. Baltimore , MD . Google Scholar 19 COLP, C., S. S. PARK & M. H. WILLIAMS, JR. 1976. Pulmonary function follow-up of 120 patients with sarcoidosis. Ann. N. Y. Acad. Sci. 278: 301–307. 10.1111/j.1749-6632.1976.tb47041.x CASPubMedWeb of Science®Google Scholar 20 DEREMEE, R. A. 1977. The present status of treatment of pulmonary sarcoidosis: A house divided. Chest 71: 388–393. 10.1378/chest.71.3.388 CASPubMedWeb of Science®Google Scholar 21 SELROOS, O. & T. L. SELLERGREN. 1979. Corticosteroid therapy of pulmonary sarcoidosis: A prospective evaluation of alternate day and daily dosage in stage III disease. Scand. J. Respir. Dis. 60: 215–221. PubMedWeb of Science®Google Scholar 22 BOTTGER, D. 1980. Results of a controlled therapeutic trial of prednisolone in chronic non-fibrotic pulmonary sarcoidosis. In Eighth International Conference on Sarcoidosis and Other Granulomatous Diseases. W. Jones Williams & B. H. Davies, Eds.: 629–631. Alpha Omega. Cardiff . Google Scholar 23 EULE, H., I. ROTH & W. WEIDE. 1980. Clinical and functional results of a controlled clinical trial of the value of prednisone therapy in sarcoidosis stage I and II. In Eighth International Conference on Sarcoidosis and Other Granulomatous Diseases. W. Jones Williams & B. H. Davies, Eds.: 624–628. Alpha Omega. Cardiff . Google Scholar 24 MIDDLETON, W. G. & A. C. DOUGLAS. 1980. Prolonged corticosteroid therapy in pulmonary sarcoidosis. In Eighth International Conference on Sarcoidosis and Other Granulomatous Diseases. W. Jones Williams & B. H. Davies, Eds.: 632–647. Alpha Omega. Cardiff . Google Scholar 25 REFVEM, O. & O. K. REFVEM. 1980. Long-term corticosteroid treatment of pulmonary sarcoidosis. In Eighth International Conference on Sarcoidosis and Other Granulomatous Diseases. W. Jones Williams and B. H. Davies, Eds.: 648–651. Alpha Omega. Cardiff . Google Scholar 26 WINTERBAUER, R. H. & J. F. HUTCHINSON. 1980. Clinical significance of pulmonary function tests on the management of sarcoidosis. Chest 78: 640–647. 10.1378/chest.78.4.640 CASPubMedWeb of Science®Google Scholar 27 HARKLEROAD, L. E., R. L. YOUNG, P. J. SAVAGE, D. W. JENKINS & R. E. LORDON. 1982. Pulmonary sarcoidosis: Long-term follow-up of the effects of steroid therapy. Chest 82: 84–87. 10.1378/chest.82.1.84 CASPubMedWeb of Science®Google Scholar 28 KEOGH, B. A. & R. G. CRYSTAL. 1980. Pulmonary function testing in interstitial pulmonary disease: What does it tell us Chest 78: 856–865. 10.1378/chest.78.6.856 CASPubMedWeb of Science®Google Scholar 29 CRYSTAL, R. G., J. E. GADEK, V. J. FERRANS, J. D. FULMER, B. R. LINE & G. W. HUNNINGHAKE. 1981. Interstitial lung disease: Current concepts of pathogenesis, staging and therapy. Am. J. Med. 70: 542–568. 10.1016/0002-9343(81)90577-5 CASPubMedWeb of Science®Google Scholar 30 NIDEN, A. H. & F. S. MISHKIN. 1983. Role of gallium-67 citrate scanning in diffuse interstitial lung disease. Pract. Cardiol. 9: 141–163. Google Scholar 31 MCKUSICK, K. A., J. S. SOIN, A. GHILADI & H. N. WAGNER. 1973. Gallium-67 accumulation in pulmonary sarcoidosis. J. Am. Med. Assoc. 223: 688. 10.1001/jama.223.6.688 CASPubMedWeb of Science®Google Scholar 32 NIDEN, A. H., F. S. MISHKIN & M. M. L. KHURANA. 1976. 67Gallium citrate lung scans in interstitial lung disease. Chest 69: 266–288. 10.1378/chest.69.2_Supplement.266 CASPubMedWeb of Science®Google Scholar 33 SIEMSEN, J. K., S. F. GREBE & A. D. WAXMAN. 1978. The use of gallium-67 in pulmonary disorders. Semin. Nucl. Med. 8: 235–249. 10.1016/S0001-2998(78)80031-2 CASPubMedWeb of Science®Google Scholar 34 NIDEN, A. H. & F. S. MISHKIN. 1979. Clinical usefulness of gallium lung scans. Compr. Ther. 5: 24–34. CASPubMedGoogle Scholar 35 BEKERMAN, C., P. B. HOFFER, J. D. BITRAN & R. G. GUPTA. 1980. Gallium-67 citrate imaging studies of the lung. Semin. Nucl. Med. 10: 286–301. 10.1016/S0001-2998(80)80007-9 CASPubMedWeb of Science®Google Scholar 36 HESHIKI, A., S. SCHATZ, K. A. MCKUSICK, D. W. BOWERSOX, J. S. SOIN & H. N. WAGNER. 1974. Gallium-67 citrate scanning in patients with pulmonary sarcoidosis. Am. J. Roentgenol. 122: 744–749. 10.2214/ajr.122.4.744 CASPubMedWeb of Science®Google Scholar 37 SIEMSEN, J. K., S. F. GREBE, E. N. SARGENT & D. WENTZ. 1976. Gallium-67 scintigraphy of pulmonary diseases as a complement to radiography. Radiology 118: 371–375. 10.1148/118.2.371 CASPubMedWeb of Science®Google Scholar 38 NOSAL, A., L. A. SCHLEISSNER, F. S. MISHKIN & J. LIEBERMAN. 1979. Angiotensin I-converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis. Ann. Intern. Med. 9: 328–331. 10.7326/0003-4819-90-3-328 Google Scholar 39 WILLIAMS, J. A., A. ANSARI, T. TANAKA, M. KHURANA, A. THOMAS, F. S. MISHKIN & A. H. NIDEN. 1979. Correlation between angiotensin converting enzyme and 67gallium scan in sarcoidosis. Am. Rev. Resp. Dis. 119(2): A86. Google Scholar 40 LINE, B. R., G. W. HUNNINGHAKE, B. A. KEOGH, A. E. JONES, G. S. JOHNSTON & R. G. CRYSTAL. 1981. Gallium-67 scanning to stage the alveolitis of sarcoidosis: Correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. Am. Rev. Respir. Dis. 123: 440–446. CASPubMedWeb of Science®Google Scholar 41 BEAUMONT, D., J. Y. HERRY, M. SAPENE, P. BOURGUET, J. J. LARZUL & B. DELABARTHE. 1982. Gallium-67 in the evaluation of sarcoidosis: Correlations with serum angiotensin-converting enzyme and bronchoalveolar lavage. Thorax 37: 11–18. 10.1136/thx.37.1.11 CASPubMedWeb of Science®Google Scholar 42 GUPTA, R. G., C. BEKERMAN, L. SICILIAN, S. OPARIL, S. M. PINSKY & J. P. SZIDON. 1982. Gallium-67 citrate scanning and serum angiotensin-converting enzyme levels in sarcoidosis. Radiology 144: 895–899. 10.1148/radiology.144.4.6287521 CASPubMedWeb of Science®Google Scholar 43 KLECH, H., H. KOHN, F. KUMMER & A. MOSTBECK. 1982. Assessment of activity in sarcoidosis: Sensitivity and specificity of 67gallium scintigraphy, serum ACE levels, chest roentgenography, and blood lymphocyte subpopulations. Chest 82: 732–738. 10.1378/chest.82.6.732 CASPubMedWeb of Science®Google Scholar 44 SCHOENBERGER, C. I., B. R. LINE, B. A. KEOGH, G. W. HUNNINGHAKE & R. G. CRYSTAL. 1982. Lung inflammation in sarcoidosis: Comparison of serum angiotensin-converting enzyme levels with bronchoalveolar lavage and gallium-67 scanning assessment of the T lymphocyte alveolitis. Thorax 37: 19–25. 10.1136/thx.37.1.19 CASPubMedWeb of Science®Google Scholar 45 KEOGH, B. A., G. W. HUNNINGHAKE, B. R. LINE & R. G. CRYSTAL. 1983. The alveolitis of pulmonary sarcoidosis: Evaluation of natural history and alveolitis-dependent changes in lung function. Am. Rev. Respir. Dis. 128: 256–265. CASPubMedWeb of Science®Google Scholar 46 LAWRENCE, E. C., R. B. TEAGUE, M. S. GOTTLIEB, S. G. JHINGRAN & J. LIEBERMAN. 1983. Serial changes in markers of disease activity with corticosteroid treatment in sarcoidosis. Am. J. Med. 74: 747–756. 10.1016/0002-9343(83)91062-8 PubMedWeb of Science®Google Scholar 47 LIEBERMAN, J., L. A. SCHLEISSNER, A. NOSAL, A. SASTRE & F. S. MISHKIN. 1983. Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis: A longitudinal study of serum ACE, 67gallium scans, chest roentgenograms, and pulmonary function. Chest 84: 522–528. 10.1378/chest.84.5.522 CASPubMedWeb of Science®Google Scholar 48 ROHATGI, P. K. & H. BAIER. 1983. Quantitative gallium scanning in pulmonary sarcoidosis. Respiration 44: 304–313. 10.1159/000194562 CASPubMedWeb of Science®Google Scholar 49 ABE, S., M. MUNAKATA, M. NISHIMURA, Y. TASUNETA, T. TERAI, I. NAKANO, Y. OHSAKI & Y. KAWAKAMI. 1984. Gallium-67 scintigraphy, bronchoalveolar lavage, and pathologic changes in patients with pulmonary sarcoidosis. Chest 85: 650–655. 10.1378/chest.85.5.650 CASPubMedWeb of Science®Google Scholar 50 LINE, B. R., J. D. FULMER, H. Y. REYNOLDS, W. C. ROBERTS, A. E. JONES, E. K. HARRIS & R. G. CRYSTAL. 1978. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: Correlation with physiologic and morphologic features and bronchoalveolar lavage. Am. Rev. Respir. Dis. 118: 355–365. CASPubMedWeb of Science®Google Scholar 51 THOMAS, A., A. H. NIDEN, F. S. MISHKIN & V. J. KAMDAR. 1984. Correlation of gallium lung scan (GLS) and pathologic activity in sarcoidosis (S) and idiopathic interstitial pneumonitis (IIP). Am. Rev. Respir. Dis. 129(2): A53. Google Scholar 52 DANIELE, R. P. & D. T. ROWLANDS. 1976. Lymphocyte subpopulations in sarcoidosis: Correlation with disease activity and duration. Ann. Intern. Med. 85: 593–600. 10.7326/0003-4819-85-5-593 CASPubMedWeb of Science®Google Scholar 53 HUNNINGHAKE, G. W., J. E. GADEK, R. C. YOUNG, JR., O. KAWANAMI, V. J. FERRANS & R. G. CRYSTAL. 1980. Maintenance of granuloma formation in pulmonary sarcoidosis by T-lymphocytes within the lung. N. Engl. J. Med. 302: 594–598. 10.1056/NEJM198003133021102 CASPubMedWeb of Science®Google Scholar 54 HUNNINGHAKE, G. W. & R. G. CRYSTAL. 1981. Pulmonary sarcoidosis: A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N. Engl. J. Med. 305: 429–434. 10.1056/NEJM198108203050804 CASPubMedWeb of Science®Google Scholar 55 HUNNINGHAKE, G. W., O. KAWANAMI, V. J. FERRANS, R. C. YOUNG, JR., W. C. ROBERTS & R. G. CRYSTAL. 1981. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am. Rev. Respir. Dis. 123: 407–412. CASPubMedWeb of Science®Google Scholar 56 HUNNINGHAKE, G. W., G. N. BEDELL, D. C. ZAVALA, M. MONICK & M. BRADY. 1983. Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis. Am. Rev. Respir. Dis. 128: 634–638. CASPubMedWeb of Science®Google Scholar Citing Literature Volume465, Issue1Tenth International Conference on Sarcoidasis and Other Granulomatous DisordersJune 1986Pages 435-443 ReferencesRelatedInformation
Referência(s)